Japanese encephalitis virus (JEV) infects a broad range of cell types in vi
tro, though little is known about the initial events of JEV infection. In t
he present study, we found that highly sulfated glycosaminoglycans (GAGs) a
re involved in infection of both neurovirulent (RP-9) and attenuated (RP-2m
s) JEV strains. Competition experiments using highly sulfated GAGs, heparin
and dextran sulfate, demonstrated an inhibition of JEV's attachment and su
bsequent infection of BHK-21 cells. Treatment of target cells by a potent s
ulfation inhibitor, sodium chlorate, greatly reduced viral binding ability
as well as infection, suggesting a critical role of GAGs' sulfation status
on the cellular surface in JEV infection. This phenomenon was confirmed by
the manifestation of a distinct binding efficiency of JEV to the wild-type
CHO cell line and its mutants with defects in GAG biosynthesis. We also dem
onstrated the binding of JEV particles and virus envelope glycoprotein to i
mmobilized heparin beads. Furthermore, the addition of heparin suppressed t
he cytopathic effects induced by JEV infection in cultured cells. Our resul
ts establish that the highly sulfated form of GAGs on cell surfaces plays a
determining role in the early stage of in vitro JEV infection. (C) 2001 Ac
ademic Press.